Rua Bioscience Ltd NZX:RUA:
RUA AND CANN REACH POSITIVE RESOLUTION IN LEGAL PROCEEDINGS
CO, CANN EXECUTED NEW SUPPLY DEALS TO SUPPORT RESPECTIVE OPERATIONS IN AUNZ MEDICINAL CANNABIS MARKETS
Rua Bioscience Says Co & Cann Reach Resolution In Legal Proceedings
Earlier from Rua Bioscience
- RUA: Revenue growth and narrowed loss offset by ongoing liquidity and going concern risks
- RUA: FY24 saw revenue growth, capital needs, and global expansion plans for Rua Bioscience
- RUA: Q1 FY25 sales surged, export channels expanded, and a capital raise is planned for further growth
Later from Rua Bioscience
- RUA: FY25 revenue soared and losses narrowed, but further capital is needed to fuel global growth
- RUA: Revenue surged, losses narrowed, and a capital raise is planned to fund further growth
- Rua Bioscience Says Sales For Q1 FY26 Are A Record
- NZ's Rua Bioscience falls to over three-month low on discounted capital raising
- Rua Bioscience Secures New Long-Term Supply Arrangement In Germany
Follow Rua Bioscience into a list and get an email when it puts out news.
Follow Rua Bioscience